Monash IVF Group Ltd (ASX:MVF)

Half Year 2026 Monash IVF Group Ltd Earnings Call Transcript

Feb 26, 2026 / 10:59 AM GMT

Release Date Price: A$0.71 (+2.90%)

Transcript

Key Points

Positve

Monash IVF Group Ltd (ASX:MVF) delivered an underlying NPAT of $10.4 million, which was at the upper end of their guidance.
The company reported improved clinical pregnancy rates, with a 49% success rate for women under 35 years of age.
Monash IVF is nearing completion of a major infrastructure project in Brisbane, which is expected to enhance capital efficiency and organic margin growth.
The company has a strong specialist retention rate, ending the half with 168 medical specialists across the group.
Monash IVF's international operations showed growth, particularly in Southeast Asia, with stimulated cycle growth in Johor, Bali, and Singapore.

Negative

Revenue for the half-year was down 1.8% compared to the prior period, reflecting softer domestic IVF volumes.
The company experienced a decline in domestic market share, down 2.5% points, primarily due to softer new patient registrations in New South Wales and Victoria.
EBITDA margin declined by 3.5% points due to industry softness, market share impacts, and non-recurring costs related to legal and compliance matters.
Day surgery episodes decreased by 4.6%, largely due to a reduction in IVF procedures.
The ultrasound business saw a decline in scans by 3%, impacting earnings negatively by $300,000.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MVF.AX - Monash IVF Group Ltd
Half Year 2026 Monash IVF Group Ltd Earnings Call
Feb 26, 2026 / NTS GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for standing by and welcome to the Monash IVF Group Limited FY26 half year results call. All participants are in a listen-only mode. There will be a presentation followed by a question-and-answer session. If you wish to ask a question, you will need to press the star key, followed by the number 1 on your telephone keypad. I would now like to hand the conference over to Dr. Victoria Atkinson, Chief Executive Officer and Managing Director. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you and good morning everyone. My name is Doctor Victoria

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.